# | Generic recommendations | Hyp. | Diab. | Dys. | Tob. | Atr. | Thr. | Exceptions |
---|---|---|---|---|---|---|---|---|
1 | If the current treatment is effective, well-tolerated and recommended by the CPG, it should be continued | ● | ● | ● | ○ | ● | ○ | 12/113 |
2 | If the current treatment is ineffective, the dose can be increased | ◐ | ● | ● | ◐ | ● | ● | 2/113 |
3 | If the current treatment is too effective, the dose can be decreased | ● | ● | n.a. | n.a. | n.a. | ● | 0/113 |
4 | If a drug of the current treatment is poorly tolerated, the dose can be decreased | ● | ● | ● | ◐ | ● | ● | 1/43 |
5 | If a treatment was not effective in the recent past, it should not be prescribed again | ● | ● | ● | ○ | ● | ○ | 15/113 |
6 | If a drug was not tolerated in the past, it should not be prescribed again | ● | ● | ● | ● | ● | ● | 0/43 |
7 | If a treatment is both poorly tolerated and ineffective, apply the recommendations for poor tolerance | ● | ● | ● | ● | ● | ● | 0/113 |
8 | Two drugs of the same pharmaco-therapeutic class should not be prescribed in association | ● | ◐ | ● | ◐ | ● | ● | 6/43 |